Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer

AbstractObjectivesRespiratory motion during PET imaging introduces quantitative and diagnostic inaccuracies, which may result in non-optimal patient management. This study investigated the effects of respiratory gating on image quantification using an amplitude-based optimal respiratory gating (ORG) algorithm.MethodsWhole body FDG-PET/CT was performed in 66 lung cancer patients. The respiratory signal was obtained using a pressure sensor integrated in an elastic belt placed around the patient’s thorax. ORG images were reconstructed with 50 %, 35 %, and 20 % of acquired PET data (duty cycle). Lesions were grouped into anatomical locations. Differences in lesion volume between ORG and non-gated images, and mean FDG-uptake (SUVmean) were calculated.ResultsLesions in the middle and lower lobes demonstrated a significant SUVmean increase for all duty cycles and volume decrease for duty cycles of 35 % and 20 %. Significant increase in SUVmean and decrease in volume for lesions in the upper lobes were observed for a 20 % duty cycle. The SUVmean increase for central lesions was significant for all duty cycles, whereas a significant volume decrease was observed for a duty cycle of 20 %.ConclusionsThis study implies that ORG could influence clinical PET imaging with respect to response monitoring and radiotherapy planning.Key Points• Quantifying lesion volume and uptake in PET is important for patient management • Respiratory motion artefacts introduce inaccuracies in quantification of PET images • Amplitude-based optimal respiratory gating maintains image quality through selection of duty cycle • The effect of respiratory gating on lesion quantification depends on anatomical location

[1]  Vincent Gregoire,et al.  Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.

[2]  Wolfgang A Weber,et al.  Use of PET for monitoring cancer therapy and for predicting outcome. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  A comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion. , 2013, International journal of radiation oncology, biology, physics.

[4]  Danny Rischin,et al.  Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Joel Karp,et al.  Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Ursula Nestle,et al.  Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  E Yorke,et al.  Four-dimensional (4D) PET/CT imaging of the thorax. , 2004, Medical physics.

[8]  W. Oyen,et al.  Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer , 2007, Journal of Nuclear Medicine.

[9]  R. Coleman,et al.  Recommendations on the Use of 18F-FDG PET in Oncology , 2008, Journal of Nuclear Medicine.

[10]  W. Oyen,et al.  Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  M. O'Doherty,et al.  FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Nan-Tsing Chiu,et al.  Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. , 2012, Radiology.

[13]  Michael Bader,et al.  Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  V. Bettinardi,et al.  Motion management in positron emission tomography/computed tomography for radiation treatment planning. , 2012, Seminars in nuclear medicine.

[15]  D. Townsend,et al.  Method for transforming CT images for attenuation correction in PET/CT imaging. , 2006, Medical physics.

[16]  S M Larson,et al.  Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.

[17]  E. Sweet,et al.  An introduction to the use of diagnostic ultrasound. , 1975, Seminars in nuclear medicine.

[18]  S. Nehmeh,et al.  Respiratory motion in positron emission tomography/computed tomography: a review. , 2008, Seminars in nuclear medicine.

[19]  John W. Clark,et al.  Implementation of an Automated Respiratory Amplitude Gating Technique for PET/CT: Clinical Evaluation , 2010, Journal of Nuclear Medicine.

[20]  L. Dunn,et al.  Motion effects on SUV and lesion volume in 3D and 4D PET scanning , 2011, Australasian Physical & Engineering Sciences in Medicine.

[21]  S. Korreman Motion in radiotherapy: photon therapy , 2012, Physics in medicine and biology.

[22]  James Hamill,et al.  Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  A. Elster,et al.  Recommendations on the Use of 18F-FDG PET in Oncology , 2009 .

[24]  M. Schwaiger,et al.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Satoshi Hattori,et al.  Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy. , 2012, European journal of radiology.

[26]  O. Schober,et al.  Respiratory gating in positron emission tomography: a quantitative comparison of different gating schemes. , 2007, Medical physics.

[27]  Cyrill Burger,et al.  PET-CT image co-registration in the thorax: influence of respiration , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  Otto S Hoekstra,et al.  Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  P. Ell,et al.  Clinical role of positron emission tomography in oncology. , 2001, The Lancet. Oncology.